Navigation Links
Depression could be evolutionary byproduct of immune system
Date:3/1/2012

Depression is common enough afflicting one in ten adults in the United States that it seems the possibility of depression must be "hard-wired" into our brains. This has led biologists to propose several theories to account for how depression, or behaviors linked to it, can somehow offer an evolutionary advantage.

Some previous proposals for the role of depression in evolution have focused on how it affects behavior in a social context. A pair of psychiatrists addresses this puzzle in a different way, tying together depression and resistance to infection. They propose that genetic variations that promote depression arose during evolution because they helped our ancestors fight infection.

An outline of their proposal appears online in the journal Molecular Psychiatry.

The co-authors are Andrew Miller, MD, William P. Timmie professor of psychiatry and behavioral sciences at Emory and director of psychiatric oncology at Winship Cancer Institute, and Charles Raison, MD, previously at Emory and now at the University of Arizona.

"Most of the genetic variations that have been linked to depression turn out to affect the function of the immune system," Miller says. "This led us to rethink why depression seems to stay embedded in the genome."

For decades, researchers have seen links between depression and inflammation, or over-activation of the immune system. People with depression tend to have higher levels of inflammation, even if they're not fighting an infection. Still, high levels of inflammatory markers are not an inevitable consequence of depression.

"The basic idea is that depression and the genes that promote it were very adaptive for helping people especially young children not die of infection in the ancestral environment, even if those same behaviors are not helpful in our relationships with other people," Raison says.

Infection was the major cause of death in humans' early history, so
'/>"/>

Contact: Kathi Baker
kobaker@emory.edu
404-727-9371
Emory University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Coming soon: Self-guided, computer-based depression treatment
2. Depression during pregnancy can double risk of preterm delivery
3. Pregnancy hormone predicts postpartum depression
4. Chantix side effects no worse with depression history
5. Children seriously affected when a parent suffers from depression
6. Researchers take first look at the genetic dynamics of inbreeding depression
7. Mothers of multiple births at increased odds of postpartum depression
8. Team identifies a molecular switch linking infectious disease and depression
9. Genetic factors may predict depression in heart disease patients
10. Depression and anxiety disorders of adolescents are not the same thing
11. Early abuse tied to more depression in children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... Calif. , July 27, 2015  Synaptics ... of human interface solutions, today announced that Huawei ... touchscreen solution for its stylish smartwatch. Huawei ... its proven reliability, low power and highly responsive ... wet finger. Huawei designers also required a classic ...
(Date:7/27/2015)... July 27, 2015   Zynx Health ™, ... clinical improvement solutions, today announced that its ... available on Android smartphones and tablets. With this ... organizations can use ZynxCarebook to securely exchange messages ... streamline care transitions to other care settings, and ...
(Date:7/23/2015)... Aware, Inc. (NASDAQ: AWRE ), a leading supplier of ... second quarter ended June 30, 2015.  Revenue ... decrease of 33% compared to $6.8 million in the same ... 2015 was $0.3 million, or $0.01 per diluted share, which ... the same period a year ago.  Lower ...
Breaking Biology News(10 mins):Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6
... In scientific publishing, how much reuse of text ... Institute at Virginia Tech and collaborators have shown that ... publication practices from thousands of full-text papers in the ... process is to find out what is restated before ...
... SAN DIEGO (October 25, 2010) Klaus ... for Allergy & Immunology, was recently awarded the prestigious ... Paris, France. A lifetime achievement award presented by ... honor in recognition of his pioneering endeavors in vascular ...
... to their feathers to stand out and attract mates, according ... Biolgica de Doňana in Seville, Spain, and colleagues. Their research ... pigments (carotenoids) from the secretions of their uropygial gland for ... the majority of birds and is situated near the base ...
Cached Biology News:Plagiarism sleuths tackle full-text biomedical articles 2La Jolla Institute scientist Klaus Ley receives Malpighi award 2La Jolla Institute scientist Klaus Ley receives Malpighi award 3Beauty from the bottom up 2
(Date:7/29/2015)... ... 2015 , ... Costello served as Lead Levee Design Engineering Manager for a ... Texas area from future storm surge flooding, such as occurred in Hurricane Ike in ... alternatives for providing protection, Costello also balanced socio-economic and environmental needs and ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... making good progress in evaluating the full range of capabilities of its unique ... tissue stem cells perform the day-to-day renewal and repair of normal tissues and ...
(Date:7/28/2015)... LONDON , July 29, 2015 ... on acquiring, rapidly developing and commercialising ... human health   Highly experienced management team; ...     Mereo BioPharma Group Ltd ... successfully raised $119m ( c. £76.5m), gross, from blue ...
(Date:7/28/2015)... ... ... The new Xsample 530 sample changer for vials can be used with Anton ... from less than 12,000 mPas (internal air) up to 36,000 (external air) – and can ... eye about Xsample 530 is its removable magazine, which is easily lifted off its hub ...
Breaking Biology Technology:Preventing Storm Surge Flooding in Houston 2Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 2Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 3Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 4Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 2Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 3Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 4Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 5Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 6Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 7Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 8Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 9Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 10Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 11New Moves in Automatic Sample Handling: Introducing Xsample 530 2
... Feb. 28, 2012 MiMedx Group, Inc. (OTCBB: MDXG), ... regenerative biomaterials and bioimplants processed from human amniotic membrane, ... 31, 2011. Full Year 2011 ResultsThe ... 31, 2011, with revenue of $7.8 million, a tenfold ...
... Professor Dr. Manfred T. Reetz honored for ... Elsevier , a world-leading provider of scientific, ... that leading German scientist, Professor Dr. Manfred T. ... Hans Meerwein Research Professor at Philipps-Universität, Marburg, has ...
... a critical care company focused on developing and commercializing ... it has enrolled the last patient into its Pivotal ... oxide (iNO) in premature infants with bronchopulmonary dysplasia (BPD).  ... last patient six weeks ahead of schedule. The trial ...
Cached Biology Technology:MiMedx Group Announces 2011 Results 2MiMedx Group Announces 2011 Results 3MiMedx Group Announces 2011 Results 4MiMedx Group Announces 2011 Results 5MiMedx Group Announces 2011 Results 6MiMedx Group Announces 2011 Results 7MiMedx Group Announces 2011 Results 8Leading German Researcher Awarded Elsevier's 2011 Tetrahedron Prize 2Leading German Researcher Awarded Elsevier's 2011 Tetrahedron Prize 3Ikaria® Completes Patient Enrollment in Pivotal Phase III Trial for Bronchopulmonary Dysplasia 2Ikaria® Completes Patient Enrollment in Pivotal Phase III Trial for Bronchopulmonary Dysplasia 3Ikaria® Completes Patient Enrollment in Pivotal Phase III Trial for Bronchopulmonary Dysplasia 4